Report Detail
Global G-CSF Biosimilars Market Professional Survey Report 2019
- RnM3751421 |
- 16 September, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product Segments: Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor
Company profiles are primarily based on public domain information including company
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Pfizer
Novartis
Roche
The global G-CSF Biosimilars market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on G-CSF Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represents overall G-CSF Biosimilars market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of G-CSF Biosimilars in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their G-CSF Biosimilars manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Segment by Application
Blood Disorders
Oncology Diseases
Chronic And Autoimmune Diseases
Growth Hormone Deficiencies
Table of Contents
Executive Summary
1 Industry Overview of G-CSF Biosimilars
- 1.1 Definition of G-CSF Biosimilars
- 1.2 G-CSF Biosimilars Segment by Type
- 1.2.1 Global G-CSF Biosimilars Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Human Growth Hormone
- 1.2.3 Erythropoietin
- 1.2.4 Monoclonal Antibodies
- 1.2.5 Insulin
- 1.2.6 Interferon
- 1.2.7 Granulocyte-Colony Stimulating Factor
- 1.3 G-CSF Biosimilars Segment by Applications
- 1.3.1 Global G-CSF Biosimilars Consumption Comparison by Applications (2014-2025)
- 1.3.2 Blood Disorders
- 1.3.3 Oncology Diseases
- 1.3.4 Chronic And Autoimmune Diseases
- 1.3.5 Growth Hormone Deficiencies
- 1.4 Global G-CSF Biosimilars Overall Market
- 1.4.1 Global G-CSF Biosimilars Revenue (2014-2025)
- 1.4.2 Global G-CSF Biosimilars Production (2014-2025)
- 1.4.3 North America G-CSF Biosimilars Status and Prospect (2014-2025)
- 1.4.4 Europe G-CSF Biosimilars Status and Prospect (2014-2025)
- 1.4.5 China G-CSF Biosimilars Status and Prospect (2014-2025)
- 1.4.6 Japan G-CSF Biosimilars Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia G-CSF Biosimilars Status and Prospect (2014-2025)
- 1.4.8 India G-CSF Biosimilars Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of G-CSF Biosimilars
- 2.3 Manufacturing Process Analysis of G-CSF Biosimilars
- 2.4 Industry Chain Structure of G-CSF Biosimilars
3 Development and Manufacturing Plants Analysis of G-CSF Biosimilars
- 3.1 Capacity and Commercial Production Date
- 3.2 Global G-CSF Biosimilars Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of G-CSF Biosimilars
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 G-CSF Biosimilars Production and Capacity Analysis
- 4.2 G-CSF Biosimilars Revenue Analysis
- 4.3 G-CSF Biosimilars Price Analysis
- 4.4 Market Concentration Degree
5 G-CSF Biosimilars Regional Market Analysis
- 5.1 G-CSF Biosimilars Production by Regions
- 5.1.1 Global G-CSF Biosimilars Production by Regions
- 5.1.2 Global G-CSF Biosimilars Revenue by Regions
- 5.2 G-CSF Biosimilars Consumption by Regions
- 5.3 North America G-CSF Biosimilars Market Analysis
- 5.3.1 North America G-CSF Biosimilars Production
- 5.3.2 North America G-CSF Biosimilars Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America G-CSF Biosimilars Import and Export
- 5.4 Europe G-CSF Biosimilars Market Analysis
- 5.4.1 Europe G-CSF Biosimilars Production
- 5.4.2 Europe G-CSF Biosimilars Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe G-CSF Biosimilars Import and Export
- 5.5 China G-CSF Biosimilars Market Analysis
- 5.5.1 China G-CSF Biosimilars Production
- 5.5.2 China G-CSF Biosimilars Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China G-CSF Biosimilars Import and Export
- 5.6 Japan G-CSF Biosimilars Market Analysis
- 5.6.1 Japan G-CSF Biosimilars Production
- 5.6.2 Japan G-CSF Biosimilars Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan G-CSF Biosimilars Import and Export
- 5.7 Southeast Asia G-CSF Biosimilars Market Analysis
- 5.7.1 Southeast Asia G-CSF Biosimilars Production
- 5.7.2 Southeast Asia G-CSF Biosimilars Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia G-CSF Biosimilars Import and Export
- 5.8 India G-CSF Biosimilars Market Analysis
- 5.8.1 India G-CSF Biosimilars Production
- 5.8.2 India G-CSF Biosimilars Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India G-CSF Biosimilars Import and Export
6 G-CSF Biosimilars Segment Market Analysis (by Type)
- 6.1 Global G-CSF Biosimilars Production by Type
- 6.2 Global G-CSF Biosimilars Revenue by Type
- 6.3 G-CSF Biosimilars Price by Type
7 G-CSF Biosimilars Segment Market Analysis (by Application)
- 7.1 Global G-CSF Biosimilars Consumption by Application
- 7.2 Global G-CSF Biosimilars Consumption Market Share by Application (2014-2019)
8 G-CSF Biosimilars Major Manufacturers Analysis
- 8.1 Pfizer
- 8.1.1 Pfizer G-CSF Biosimilars Production Sites and Area Served
- 8.1.2 Pfizer Product Introduction, Application and Specification
- 8.1.3 Pfizer G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Novartis
- 8.2.1 Novartis G-CSF Biosimilars Production Sites and Area Served
- 8.2.2 Novartis Product Introduction, Application and Specification
- 8.2.3 Novartis G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Roche
- 8.3.1 Roche G-CSF Biosimilars Production Sites and Area Served
- 8.3.2 Roche Product Introduction, Application and Specification
- 8.3.3 Roche G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Merck & Co.
- 8.4.1 Merck & Co. G-CSF Biosimilars Production Sites and Area Served
- 8.4.2 Merck & Co. Product Introduction, Application and Specification
- 8.4.3 Merck & Co. G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Sanofi
- 8.5.1 Sanofi G-CSF Biosimilars Production Sites and Area Served
- 8.5.2 Sanofi Product Introduction, Application and Specification
- 8.5.3 Sanofi G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Johnson & Johnson
- 8.6.1 Johnson & Johnson G-CSF Biosimilars Production Sites and Area Served
- 8.6.2 Johnson & Johnson Product Introduction, Application and Specification
- 8.6.3 Johnson & Johnson G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Gilead Science
- 8.7.1 Gilead Science G-CSF Biosimilars Production Sites and Area Served
- 8.7.2 Gilead Science Product Introduction, Application and Specification
- 8.7.3 Gilead Science G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 GlaxoSmithKline
- 8.8.1 GlaxoSmithKline G-CSF Biosimilars Production Sites and Area Served
- 8.8.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.8.3 GlaxoSmithKline G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 AbbVie
- 8.9.1 AbbVie G-CSF Biosimilars Production Sites and Area Served
- 8.9.2 AbbVie Product Introduction, Application and Specification
- 8.9.3 AbbVie G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Amgen
- 8.10.1 Amgen G-CSF Biosimilars Production Sites and Area Served
- 8.10.2 Amgen Product Introduction, Application and Specification
- 8.10.3 Amgen G-CSF Biosimilars Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 AstraZeneca
- 8.12 Bayer
9 Development Trend of Analysis of G-CSF Biosimilars Market
- 9.1 Global G-CSF Biosimilars Market Trend Analysis
- 9.1.1 Global G-CSF Biosimilars Market Size (Volume and Value) Forecast 2019-2025
- 9.2 G-CSF Biosimilars Regional Market Trend
- 9.2.1 North America G-CSF Biosimilars Forecast 2019-2025
- 9.2.2 Europe G-CSF Biosimilars Forecast 2019-2025
- 9.2.3 China G-CSF Biosimilars Forecast 2019-2025
- 9.2.4 Japan G-CSF Biosimilars Forecast 2019-2025
- 9.2.5 Southeast Asia G-CSF Biosimilars Forecast 2019-2025
- 9.2.6 India G-CSF Biosimilars Forecast 2019-2025
- 9.3 G-CSF Biosimilars Market Trend (Product Type)
- 9.4 G-CSF Biosimilars Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 G-CSF Biosimilars Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on G-CSF Biosimilars. Industry analysis & Market Report on G-CSF Biosimilars is a syndicated market report, published as Global G-CSF Biosimilars Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of G-CSF Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
